Ipsen SA
PAR:IPN

Watchlist Manager
Ipsen SA Logo
Ipsen SA
PAR:IPN
Watchlist
Price: 103.3 EUR -0.77% Market Closed
Market Cap: 8.7B EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+5%
Operating Income
Forecast
+42%
Net Income
Forecast
N/A

Wall Street
Price Targets

IPN Price Targets Summary
Ipsen SA

Wall Street analysts forecast IPN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPN is 127.41 EUR with a low forecast of 101 EUR and a high forecast of 163.8 EUR.

IPN Lowest Forecast
Wall Street Target
101 EUR
2% Downside
IPN Average Forecast
Wall Street Target
127.41 EUR
23% Upside
IPN Highest Forecast
Wall Street Target
163.8 EUR
59% Upside
Lowest
Price Target
101 EUR
2% Downside
Average
Price Target
127.41 EUR
23% Upside
Highest
Price Target
163.8 EUR
59% Upside
Ipsen SA Competitors:
Price Targets
C
2M7C
China Medical System Holdings Ltd
1% Downside
GSK
GlaxoSmithKline PLC
9% Upside
P
300363
Porton Pharma Solutions Ltd
34% Upside
CRMD
CorMedix Inc
15% Upside
C
2M7C
China Medical System Holdings Ltd
1% Downside
GSK
GlaxoSmithKline PLC
9% Upside
P
300363
Porton Pharma Solutions Ltd
34% Upside
CRMD
CorMedix Inc
15% Upside
PHAT
Phathom Pharmaceuticals Inc
69% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
11% Upside
G
605507
Guobang Pharma Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
Ipsen SA

For the last 8 years the compound annual growth rate for Ipsen SA's revenue is 10%. The projected CAGR for the next 3 years is 6%.

10%
Past Growth
6%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ipsen SA

For the last 8 years the compound annual growth rate for Ipsen SA's operating income is 8%. The projected CAGR for the next 3 years is 21%.

8%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ipsen SA

For the last 8 years the compound annual growth rate for Ipsen SA's net income is 5%. The projected CAGR for the next 3 years is 43%.

5%
Past Growth
43%
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

See Also

Summary
IPN intrinsic value, competitors valuation, and company profile.
DCF Valuation
IPN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IPN stock valuation using valuation multiples.
Wall Street Estimates
IPN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IPN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IPN's stock price target?
Price Target
127.41 EUR

According to Wall Street analysts, the average 1-year price target for IPN is 127.41 EUR with a low forecast of 101 EUR and a high forecast of 163.8 EUR.

What is Ipsen SA's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Ipsen SA's revenue is 10%. The projected CAGR for the next 3 years is 6%.

What is Ipsen SA's Operating Income forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for Ipsen SA's operating income is 8%. The projected CAGR for the next 3 years is 21%.

What is Ipsen SA's Net Income forecast?
Projected CAGR
43%

For the last 8 years the compound annual growth rate for Ipsen SA's net income is 5%. The projected CAGR for the next 3 years is 43%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.